Metabolic syndrome and NASH - PubMed (original) (raw)

Review

. 2007 Feb;11(1):105-17, ix.

doi: 10.1016/j.cld.2007.02.013.

Affiliations

Review

Metabolic syndrome and NASH

Giulio Marchesini et al. Clin Liver Dis. 2007 Feb.

Abstract

Clinical and epidemiologic studies have associated non-alcoholic fatty liver with the metabolic syndrome, with insulin resistance as the pivotal pathogenic factor. Obesity, type 2 diabetes mellitus, dyslipidemia, and hypertension contribute to risk for liver disease and to disease progression. The presence of multiple metabolic abnormalities is associated with the severity of liver disease. Patients have a high risk for cardiovascular morbidity and mortality, mediated by early atherosclerosis. This evidence has precise therapeutic implications: only a behavioral approach to lifestyle correction will address all alterations characterizing the metabolic syndrome, including metabolic liver disease.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources